Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New update dates were added (2026-05-21 and 2026-05-22) and older dates (2026-05-12, 2026-05-13, and 2025-11) were removed from the Study Record Dates, reflecting recent administrative updates to the page.
    Difference
    0.1%
    Check dated 2026-05-26T11:58:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new Sample Collection section was added to the study plan, and the record was updated to revision v3.5.4, signaling changes in how specimens are collected and documented for the trial.
    Difference
    0.2%
    Check dated 2026-05-19T05:23:10.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    The page footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site versioning change rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T11:51:48.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T05:57:08.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:15:35.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T12:36:41.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.